Table 3.
Univariate and multivariate analysis of potential prognostic factors for overall survival
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Age(years) (≤ 50 vs >50) | 1.024 | 1.007–1.040 | 0.004 | 1.017 | 1.000–1.035 | 0.046 |
| FIGO Stage(I vs II vs III vs IV) | 2.028 | 1.573–2.614 | <0.001 | 1.577 | 1.189–2.091 | 0.002 |
| Grade(G1 vs G2 vs G3) | 1.176 | 0.915–1.512 | 0.206 | |||
| Residual tumor (≤2 cm vs >2 cm) | 3.352 | 2.267–4.955 | <0.001 | 2.337 | 1.518–3.597 | <0.001 |
| Histological subtype | 0.821 | 0.700–0.962 | 0.015 | |||
| Ascites(yes vs no) | 1.671 | 1.127–2.479 | 0.011 | |||
| Albumin | 0.928 | 0.889–0.967 | <0.001 | |||
| CRP level | 1.005 | 1.001–1.009 | 0.027 | |||
| CA-125 | 1.000 | 1.000–1.000 | 0.145 | |||
| GPS | 1.383 | 1.042–1.835 | 0.025 | |||
| mGPS | 1.409 | 1.061–1.873 | 0.018 | |||
| PNI | 1.787 | 1.212–2.634 | 0.003 | |||
| NLR | 1.407 | 0.885–2.238 | 0.149 | |||
| PI | 1.377 | 1.035–1.832 | 0.028 | |||
| PLR | 1.921 | 1.207–3.056 | 0.006 | |||
| CRP/Alb ratio | 1.287 | 1.139–1.454 | <0.001 | 1.330 | 1.131–1.564 | 0.001 |
HR hazard ratio, FIGO International Federation of Gynecologists and Obstetricians, G grade, CRP C-reactive protein, CA cancer antigen, GPS Glasgow Prognostic Score, mGPS modified, GPS PNI Prognostic Nutritional Index, NLR Neutrophil lymphocyte ratio, PI Prognostic index, PLR Platelet lymphocyte ratio, Alb Albumin